Semaglutide attenuates diabetic retinopathy progression via ameliorating retinal vasculopathy and oxidative stress in vivo and in vitro.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Semaglutide attenuates diabetic retinopathy progression via ameliorating retinal vasculopathy and oxidative stress in vivo and in vitro.
- Published In:
- Diabetes, obesity & metabolism, 27(12), 7085-7096 (2025)
- Authors:
- Cheng, Xiao, Fu, Zhuoxin, Chen, Yucai, Wang, Jiawei, Han, Furong
- Database ID:
- RPEP-10445
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10445APA
Cheng, Xiao; Fu, Zhuoxin; Chen, Yucai; Wang, Jiawei; Han, Furong. (2025). Semaglutide attenuates diabetic retinopathy progression via ameliorating retinal vasculopathy and oxidative stress in vivo and in vitro.. Diabetes, obesity & metabolism, 27(12), 7085-7096. https://doi.org/10.1111/dom.70107
MLA
Cheng, Xiao, et al. "Semaglutide attenuates diabetic retinopathy progression via ameliorating retinal vasculopathy and oxidative stress in vivo and in vitro.." Diabetes, 2025. https://doi.org/10.1111/dom.70107
RethinkPeptides
RethinkPeptides Research Database. "Semaglutide attenuates diabetic retinopathy progression via ..." RPEP-10445. Retrieved from https://rethinkpeptides.com/research/cheng-2025-semaglutide-attenuates-diabetic-retinopathy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.